Piramal Pharma Limited
PPLPHARMA.NS
$-0.15
Change (1 day)
$2.90
Year High
$1.04
Year Low
Categories
Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products, as well as provides various pharma services, including injection, HPAPI, etc. The company was incorporated in 2020 and is based in Mumbai, India. Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited.
P/S ratio for Piramal Pharma Limited (PPLPHARMA.NS)
P/S ratio as of 2023: 2.02
According to Piramal Pharma Limited's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.02. At the end of 2022 the company had a P/S ratio of 1.15.
P/S ratio history for Piramal Pharma Limited from 2020 to 2023
P/S ratio at the end of each year
| Year | P/S ratio |
|---|---|
| 2023 | 2.02 |
| 2022 | 1.15 |
| 2021 | 7.24 |
| 2020 | 7.68 |